A bstract Predicting protein-ligand binding affinity is crucial for drug discovery, as it enables efficient identification of drug candidates. We introduce PLAPT, a novel model utilizing transfer learning from pre-trained transformers like ProtBERT and ChemBERTa to predict binding affinities with high accuracy. Our method processes one-dimensional protein and ligand sequences, leveraging a branching neural network architecture for feature integration and affinity estimation. We demonstrate PLAPT’s superior performance through validation on multiple datasets, achieving state-of-the-art results while requiring significantly less computational resources for training compared to existing models. Our findings indicate that PLAPT offers a highly effective and accessible approach for accelerating drug discovery efforts.
No takes yet. Share an insight, caveat, or question.
Rose et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: